$37.83
Value $982M
HIPO and JPM stock compared: price, dividend, valuation and results, from SEC filings.
$37.83
Value $982M
$329.14
Value $888B
Hippo (HIPO) has a market value of $982M and JP Morgan Chase & Co. (JPM) $888B. Over the last year, with dividends, HIPO moved +19.9% and JPM +11.7%. The P/E is 30.7 for HIPO and 13.8 for JPM. Dividend yield: HIPO none, JPM 1.87%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
HIPO$982M
JPM$888B
JPM is 904 times HIPO
Revenue, 12 months
HIPO$543M
JPM$203B
JPM is 374 times HIPO
Net income, 12 months
HIPO$32M
JPM$66.0B
JPM is 2,062 times HIPO
Operating margin
HIPO–
JPM–
ROIC
HIPO7.1%
JPM15.1%
8.0 points apart
P/E
HIPO30.7
JPM13.8
HIPO is 2.2 times JPM
Dividend yield
HIPO0.0%
JPM1.9%
1.9 points apart
5-year return
HIPO-60.5%
JPM+126.6%
187.1 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
HIPO-60.5%
JPM+126.6%
| Period | HIPOWith dividends | JPMWith dividends |
|---|---|---|
| 1 year since November 17, 2025 | +19.9%Price +19.9% | +11.7%Price +9.6% |
| 3 years since November 17, 2023 | +368.8%+67.4% a yearPrice +368.8% | +129.5%+31.9% a yearPrice +115.3% |
| 5 years since November 17, 2021 | -60.5%-17.0% a yearPrice -60.5% | +126.6%+17.8% a yearPrice +100.1% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
HIPOHippoJPMJP Morgan Chase & Co.
| Price | $37.83 | $329.14 |
|---|---|---|
| Market value | $982M | $888B |
| Enterprise value (EV) | $608M | – |
| P/E | 30.7 | 13.8 |
| P/E, 5-year median | – | 11.1 |
| P/B | 2.1 | 2.5 |
| EV/EBIT | 17.9 | – |
| Free cash flow yield | 12.9% | – |
| Revenue, 12 months | $543M | $203B |
|---|---|---|
| Net income, 12 months | $32M | $66.0B |
| Free cash flow, 12 months | $127M | – |
| Earnings per share, 12 months | $1.23 | $23.85 |
| Revenue growth, year on year | 25.9% | 2.8% |
| Revenue growth a year, past | +55.5%over 5 years | +8.8%over 5 years |
| EPS growth a year, past | – | +17.7%over 5 years |
| Gross margin | – | – |
|---|---|---|
| Operating margin | – | – |
| Net margin | 5.9% | 32.5% |
| ROIC | 7.1% | 15.1% |
| ROE | 7.1% | 18.0% |
| Cash | $375M | $1.11T |
|---|---|---|
| Total debt | $3.2M | $531B |
| Net debt / EBITDA | -6.9 | – |
| Interest cover | – | – |
| Dividend yield | – | 1.9% |
|---|---|---|
| Dividend per share, 12 months | – | $6.15 |
| Dividend growth a year, past | – | +10.0%over 5 years |
| Buyback yield | 1.5% | 3.6% |
| Shareholder yield | 1.5% | 5.4% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, JP Morgan Chase & Co. ($888B) is about 903.5 times Hippo ($982M), at today's prices.
Since November 17, 2021, HIPO's price moved -60.5% and JPM's +100.1%. With dividends: HIPO -60.5% (-17.0% a year), JPM +126.6% (+17.8% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for Hippo and 1.87% for JP Morgan Chase & Co.. Over the last twelve months they paid – and $6.15 per share.
At today's price, the P/E is 30.7 for HIPO and 13.8 for JPM. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 5.9% for Hippo and 32.5% for JP Morgan Chase & Co., and the operating margin – and –. Revenue was $543M and $203B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.